BLOOD-CELLS PARTICIPATE IN THE FIBRINOLYTIC RESPONSE TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR
- 1 August 1987
- journal article
- research article
- Vol. 70 (2) , 564-567
Abstract
Exercise and venous occlusion stimulate fibrinolysis. In addition to increased concentrations of tissue-type plasminogen activator (tPA) and increased plasmin-mediated fibrinolysis in plasma, these stimuli produce additional cellular-phase activity in blood that is of the same magnitude as the plasma response. To determine whether tPA alone, rather than other consequences of these stimuli, is responsible for the cellular response, the in vitro effects of tPA on whole blood, plasma, and calculated cellular-phase (whole blood minus plasma) activities were determined by solid-phase radiofibrin assay on venous blood from ten normal subjects (seven men, three women). At tPA concentrations encompassing physiological and therapeutic levels (5 to 100 ng/mL; 0.7 to 14 IU/mL), increments in whole blood were consistently in excess of those in companion plasma and represented increased cellular-phase activity equivalent in magnitude to the well-known increase in plasma activity. Fibrinolytic activity produced by 10 to 20 ng tPA/mL (1.4 to 2.8 IU/mL) was consistently detected in whole blood and plasma by 60 minutes, with higher concentrations (100 ng or 14 IU tPA/mL) detectable after a five-minute assay in all subjects. Thus, tPA alone, without invoking fibrinolytic factors extraneous to blood or other effects of exercise or venous occlusion, accounts for both cellular and plasma responses to these stimuli. The considerable cellular response, the mechanism of which remains to be elucidated, may constitute a determinant of individual therapeutic responsiveness to tPA.This publication has 12 references indexed in Scilit:
- Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.Circulation, 1986
- Coronary Thrombolysis with Recombinant Tissue-Type Plasminogen ActivatorAnnals of Internal Medicine, 1985
- Participation of blood cells in exercise-induced fibrinolysisThrombosis Research, 1985
- Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1985
- MEASUREMENT OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY A 2-SITE IMMUNORADIOMETRIC ASSAY1983
- EFFECT OF ASPIRIN AND SODIUM-SALICYLATE ON THROMBOSIS, FIBRINOLYSIS, PROTHROMBIN TIME, AND PLATELET SURVIVAL IN RABBITS WITH INDWELLING AORTIC CATHETERS1983
- Plasminogen activator release during venous stasis and exercise as determined by a new specific assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- The major fibrinolytic proteases of human leukocytesBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Increased Blood Fibrinolytic Activity after Aspirin IngestionNew England Journal of Medicine, 1977
- FIBRINOLYSIS IN NORMAL PLASMA AND BLOOD - EVIDENCE FOR SIGNIFICANT MECHANISMS INDEPENDENT OF PLASMINOGEN-PLASMIN SYSTEM1976